Abstract
The process of replacing or regenerating human cells, tissues, or organs to restore or establish normal function is known as REGENERATIVE MEDICINE. It is a brand new, developing field of medicine that deals with the functional repair of tissues or organs damaged by severe trauma or degenerative conditions. Currently, platelet-rich plasma (PRP) and stem cell-based treatments are the two competing technologies that can heal and restore the injured tissues. Platelet-rich plasma (PRP) applications used in new autologous cellular therapeutics have the potential to supplement a range of regenerative medicine therapy regimens [1]. An emerging and effective treatment alternative in musculoskeletal therapy is platelet-rich plasma (PRP) PRP is an autologous plasma preparation that has been enhanced with platelet concentrations above those seen in whole blood ordinarily. High platelet concentration has therapeutic promise because of their ability to give supraphysiologic levels of vital growth factors, which operate as a regenerative stimulus to encourage repair in tissues with poor healing capabilities [2]. A concentration of platelet-rich protein generated from blood that has been spun to remove the red blood cells is known as platelet-rich plasma (PRP), or more accurately autologous conditioned plasma. Despite being advertised to cure a variety of medical ailments, there is conflicting evidence for profit as of 2020, with some evidence supporting usage in some circumstances and opposing use in other. A unique substance that is being employed in several surgical specialities is platelet-rich plasma. The aim of the article is to review the ongoing and prospective utilization of platelet-rich plasma in the field of Otolaryngology [3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have